The FTSE 100’s 3 Best Dividend Stocks: National Grid plc, British American Tobacco plc And Admiral Group plc

These 3 stocks have huge income potential: National Grid plc (LON: NG), British American Tobacco plc (LON: BATS) and Admiral Group plc (LON: ADM)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With interest rates still at just 0.5% and apparently unlikely to post brisk gains in the coming years, dividends remain a crucial aspect of investing. That’s amplified by the disappointing returns currently available on the FTSE 100, with the index yo-yoing between 6000 points and around 6200 points in recent weeks.

Therefore, buying companies such as National Grid (LSE: NG) appears to be a sound move. For starters, it offers a yield of 4.7%, which is many times higher than the best savings rates on offer, but also because National Grid offers a stability and reliability when it comes to dividend payments that is hard to match.

For example, National Grid’s business model is highly resilient and is perhaps the least cyclical of all companies listed on the FTSE 100. Because it is focused on energy transmission, rather than supply, it does not seem to come with the same degree of political risk as other non-cyclical utility companies which are often criticised in the media and politicians and, therefore, suffer from weaker investor sentiment. Furthermore, National Grid has increased dividends per share in each of the last five years and, with dividends being covered 1.35 times by profit, there is sufficient headroom to allow for continued rises in future years.

Similarly, British American Tobacco (LSE: BATS) is also a reliable dividend payer, with its shareholder payouts having risen at an annualised rate of 6.5% during the last five years. Although dividends now represent 75% of profit, there is scope for British American Tobacco’s payout ratio to increase owing to the fact that it is a very mature business which does not need to reinvest substantial sums in order to grow. This should mean that the company’s 4.2% yield continues to rise in future years.

In addition, British American Tobacco also has substantial growth potential, with its move into e-cigarettes having the scope to deliver top and bottom line rises as the world becomes increasingly health conscious. And, while it has its own e-cigarette offering called Vype, M&A activity could easily be undertaken in future to give British American Tobacco a stronger hold on the new industry.

Meanwhile, insurance company Admiral (LSE: ADM) remains one of the highest yielding shares in the FTSE 100, with its yield currently standing at 6.3%. Clearly, there are potentially challenging times ahead for the company, with changes to insurance premium tax likely to impact on the wider market and cause a degree of pressure on margins moving forward.

However, Admiral remains a well-run business with an excellent track record of profit growth. In fact, its bottom line has risen at an annualised rate of 11.7% during the last five years and, while growth of just 1% is being forecast for next year, Admiral’s longer term prospects remain bright due to its niche offering and strong competitive position within the car insurance space.

Peter Stephens owns shares of Admiral Group, British American Tobacco, and National Grid. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »